FB

Franklin Berger

North America, New York, United States, New York

Description

Franklin Berger has served as a member of our board of directors since September 2010. Franklin Berger is a consultant to biotechnology indu...

Investor Profile

Franklin Berger has made 7 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (29%)
  • Series B (29%)
  • Seed (29%)
  • Series C (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Wellness
  • Manufacturing
  • Medical
  • Medical Device
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Franklin Berger frequently co-invest with?

E Squared Capital Management
North America, New York, United States, New York
Co-Investments: 2
Qiming Venture Partners USA
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 3
Apollo Health Ventures
Europe, Hamburg, Germany, Hamburg
Co-Investments: 2
BrightEdge Fund
North America, Georgia, United States, Atlanta
Co-Investments: 3
Syno Capital
North America, New York, United States, New York
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
AB
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 3
Co-Investments: 2

Which angels does Franklin Berger often collaborate with?

PL
North America, California, United States, Palo Alto
Shared Deals: 1
KY
North America, New Hampshire, United States, Manchester
Shared Deals: 1
CG
North America, California, United States, San Francisco
Shared Deals: 1
DL
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Franklin Berger?

Auron Therapeutics

Newton, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
Series BFeb 4, 2025
Amount Raised: $27,000,000
Auron Therapeutics

Wellesley, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
Series AJul 20, 2022
Amount Raised: $48,000,000
MindRhythm

Cupertino, California, United States

MindRhythm is an evolved neurodiagnostics company discovering and developing unique biometrics to solve unmet needs in medicine.

ManufacturingMedicalMedical Device
SeedAug 24, 2021
Amount Raised: $5,000,000
Auron Therapeutics

Wellesley, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
SeedJan 28, 2021
Amount Raised: $12,750,000
Amphivena Therapeutics

South San Francisco, California, United States

Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics.

BiotechnologyHealth CareOncologyTherapeutics
Series CSep 24, 2019
Amount Raised: $62,000,000
Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series BFeb 1, 2019
Amount Raised: $25,000,000
Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series AFeb 8, 2017
Amount Raised: $6,067,875